"Créée en 1970 et située au Nord-Ouest de Lyon, la Clinique de la Sauvegarde - Ramsay Santé est un établissement de santé privé pluridisciplinaire de proximité reconnu pour ses nombreuses filières spécialisées. L’établissement est également labellisé Centre Spécialisé de l’Obésité. Avec une capacité d’accueil de 230 lits et places, un service d’urgences ouvert 7j/7 et 24h/24 et des moyens de traitements et d’exploration sur le même site, l’établissement offre une prise en charge globale à ses patients. Par ailleurs, la Clinique de la Sauvegarde dispose d’une hélistation permettant de prendre en charge les urgences vitales des patients de toute la région."

During the past decade, Clinique de la Sauvegarde conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique de la Sauvegarde" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 4 trials, followed by "GCS Ramsay Santé pour l'Enseignement et la Recherche" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Hospices Civils de Lyon" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique de la Sauvegarde" #1 collaborator was "UNICANCER" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Bicetre Hospital" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Clinique de la Sauvegarde" are "Breast Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials), "DLBCL" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Clinique de la Sauvegarde" in a lesser frequency.

Most popular intervention types in "Clinique de la Sauvegarde" are "Drug" (26 trials), "Other" (8 trials), "Procedure" (7 trials), "Device" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (3 trials), "Bevacizumab" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique de la Sauvegarde" are 39 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique de la Sauvegarde". 2 are not yet recruiting, 13 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Clinique de la Sauvegarde, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique de la Sauvegarde, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".